Veldwijk Jorien, Lambooij Mattijs S, Bruijning-Verhagen Patricia C J, Smit Henriette A, de Wit G Ardine
National Institute for Public Health and the Environment, Center for Prevention and Health Services Research, Bilthoven, The Netherlands; University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
National Institute for Public Health and the Environment, Center for Prevention and Health Services Research, Bilthoven, The Netherlands.
Vaccine. 2014 Oct 29;32(47):6277-83. doi: 10.1016/j.vaccine.2014.09.004. Epub 2014 Sep 16.
This study aimed to identify characteristics that affect parental decisions about rotavirus vaccination, to determine the relative importance of those characteristics and subsequently to estimate vaccination coverage for different implementation strategies.
A Discrete choice experiment (DCE) questionnaire was sent to the parents of 1250 newborns aged 6 weeks (response rate 37.3%). Mixed-logit models were used to estimate the relative importance of the five included rotavirus vaccine and implementation characteristics; vaccine effectiveness, frequency of severe side effects, protection duration, the healthcare facility that administrates vaccination and out-of-pocket costs. Based on the utility functions of the mixed-logit model, the potential vaccination coverage was estimated for different vaccine scenarios and implementation strategies.
All characteristics, except for healthcare facility that administrates vaccination, influenced parental willingness to vaccinate their newborn against rotavirus. Parents were willing to trade 20.2 percentage points vaccine effectiveness for the lowest frequency of severe side effects (i.e., 1 in 1,000,000) or 20.8 percentage points for a higher protection duration. Potential vaccination coverage ranged between 22.7 and 86.2%, depending on vaccine scenario (i.e., vaccine effectiveness and protection duration) and implementation strategy (i.e., out-of-pocket costs and healthcare facility that administrates vaccination).
When deciding about vaccination against rotavirus, parents are mostly driven by the out-of-pocket costs, vaccine effectiveness, protection duration, and frequency of severe side effects. The highest vaccination coverage is expected for a vaccine with high effectiveness and protection duration that is implemented within the current National Immunization Program context. Implementation of the same rotavirus vaccine in the free market will result in lowest coverage.
本研究旨在确定影响父母关于轮状病毒疫苗接种决策的特征,确定这些特征的相对重要性,并随后估计不同实施策略下的疫苗接种覆盖率。
向1250名6周龄新生儿的父母发送了离散选择实验(DCE)问卷(回复率37.3%)。使用混合逻辑模型估计所纳入的五种轮状病毒疫苗及实施特征的相对重要性;疫苗效力、严重副作用发生频率、保护持续时间、进行疫苗接种的医疗机构以及自付费用。基于混合逻辑模型的效用函数,估计了不同疫苗方案和实施策略下的潜在疫苗接种覆盖率。
除进行疫苗接种的医疗机构外,所有特征均影响父母为其新生儿接种轮状病毒疫苗的意愿。父母愿意用20.2个百分点的疫苗效力换取最低的严重副作用发生频率(即百万分之一),或用20.8个百分点换取更长的保护持续时间。潜在疫苗接种覆盖率在22.7%至86.2%之间,具体取决于疫苗方案(即疫苗效力和保护持续时间)和实施策略(即自付费用和进行疫苗接种的医疗机构)。
在决定是否接种轮状病毒疫苗时,父母主要受自付费用、疫苗效力、保护持续时间和严重副作用发生频率的驱动。在当前国家免疫规划背景下实施的具有高效力和保护持续时间的疫苗预计接种覆盖率最高。在自由市场中实施相同的轮状病毒疫苗将导致最低的覆盖率。